These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 34508324)
1. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital. Flores-Paredes W; Luque N; Albornoz R; Rojas N; Espinoza M; Pons MJ; Ruiz J Infect Chemother; 2021 Sep; 53(3):449-462. PubMed ID: 34508324 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital. Pandey R; Mishra SK; Shrestha A Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185 [TBL] [Abstract][Full Text] [Related]
3. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921 [TBL] [Abstract][Full Text] [Related]
4. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico. Llaca-Díaz JM; Mendoza-Olazarán S; Camacho-Ortiz A; Flores S; Garza-González E Chemotherapy; 2012; 58(6):475-81. PubMed ID: 23548324 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic Consumption and Its Relationship with Bacterial Resistance Profiles in ESKAPE Pathogens in a Peruvian Hospital. Pérez-Lazo G; Abarca-Salazar S; Lovón R; Rojas R; Ballena-López J; Morales-Moreno A; Flores-Paredes W; Arenas-Ramírez B; Illescas LR Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680802 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania. Arbune M; Gurau G; Niculet E; Iancu AV; Lupasteanu G; Fotea S; Vasile MC; Tatu AL Infect Drug Resist; 2021; 14():2369-2378. PubMed ID: 34194233 [TBL] [Abstract][Full Text] [Related]
7. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania. Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670 [TBL] [Abstract][Full Text] [Related]
8. Occurrence and characterization of ESKAPE organisms on the hands of veterinary students before patient contact at a veterinary academic hospital, South Africa. Sebola DC; Oguttu JW; Malahlela MN; Kock MM; Qekwana DN BMC Vet Res; 2024 Oct; 20(1):475. PubMed ID: 39420336 [TBL] [Abstract][Full Text] [Related]
9. Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India. Kharat AS; Makwana N; Nasser M; Gayen S; Yadav B; Kumar D; Veeraraghavan B; Mercier C Int J Antimicrob Agents; 2024 May; 63(5):107125. PubMed ID: 38431109 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance of ESKAPE group-microorganisms in health institutions from Hermosillo and Ciudad Obregón, Sonora, México. Álvarez-Ainza ML; Fong-Coronado PA; Ruiz-Bustos E; Castillón-Campaña LG; Quintero-Reyes IE; Duarte-Zambrano LA; Bolado-Martínez E Front Cell Infect Microbiol; 2024; 14():1348093. PubMed ID: 38516533 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952 [TBL] [Abstract][Full Text] [Related]
12. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Zhen X; Lundborg CS; Sun X; Hu X; Dong H Antimicrob Resist Infect Control; 2019; 8():137. PubMed ID: 31417673 [TBL] [Abstract][Full Text] [Related]
13. Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary. Orosz L; Lengyel G; Ánosi N; Lakatos L; Burián K Acta Microbiol Immunol Hung; 2022 Jan; ():. PubMed ID: 35084364 [TBL] [Abstract][Full Text] [Related]
14. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146 [TBL] [Abstract][Full Text] [Related]
15. ESKAPE Pathogens: Antimicrobial Resistance Patterns, Risk Factors, and Outcomes a Retrospective Cross-Sectional Study of Hospitalized Patients in Palestine. Abukhalil AD; Barakat SA; Mansour A; Al-Shami N; Naseef H Infect Drug Resist; 2024; 17():3813-3823. PubMed ID: 39247758 [TBL] [Abstract][Full Text] [Related]
16. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients. Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409 [TBL] [Abstract][Full Text] [Related]
17. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa. Founou RC; Founou LL; Allam M; Ismail A; Essack SY Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772 [TBL] [Abstract][Full Text] [Related]
18. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017. Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955 [TBL] [Abstract][Full Text] [Related]
19. ESKAPE pathogens in pediatric cardiac surgery patients: 5-year microbiological monitoring in a tertiary hospital in Kazakhstan. Baigenzhin A; Bissenova N; Yergaliyeva A; Marassulov S; Tuleubayeva E; Aitysheva U Acta Microbiol Immunol Hung; 2024 Sep; 71(3):211-219. PubMed ID: 39190489 [TBL] [Abstract][Full Text] [Related]
20. A 2-Year Single-Centre Audit on Antibiotic Resistance of Feretzakis G; Loupelis E; Sakagianni A; Skarmoutsou N; Michelidou S; Velentza A; Martsoukou M; Valakis K; Petropoulou S; Koutalas E Antibiotics (Basel); 2019 May; 8(2):. PubMed ID: 31096587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]